Skip to main content
. Author manuscript; available in PMC: 2024 Oct 1.
Published in final edited form as: Lancet Respir Med. 2023 May 22;11(10):873–882. doi: 10.1016/S2213-2600(23)00155-8

Figure 3:

Figure 3:

Visualization of mediation results for clinical worsening for A) REVEAL 2.0, B) REVEAL Lite 2, C) COMPERA, D) COMPERA 2.0, and E) FPHR risk score mediators. Size of direct and indirect effect lines were weighted according to the relative size of the effects.